Zogenix Archives -

Zogenix has bounced back from the FDA’s rejection of its only drug, with the acquisition of Modis Therapeutics

After epilepsy setback, Zogenix buys Modis and rare disease drug for $400m

https://pharmaphorum.com/news/after-epilepsy-setback-zogenix-buys-modis-and-rare-disease-drug-for-400m/

Market Access/ News/ News

Zogenix slumps after FDA refuses epilepsy drug file

Phil Taylor epilepsy, fda, Zogenix 0 Comment

Zogenix’s only drug candidate is facing a long delay after the FDA refused to accept its marketing application,

Zogenix slumps after FDA refuses epilepsy drug file

https://pharmaphorum.com/news/zogenix-slumps-after-fda-refuses-epilepsy-drug-file/

Market Access/ News/ News/ News/ R&D/ R&D/ US

Zogenix gains Breakthrough status, but GW Pharma still ahead in Dravet syndrome

Andrew McConaghie Breakthrough Therapy Designation, Dravet syndrome, Zogenix 0 Comment

The FDA has granted Zogenix a Breakthrough Therapy Designation for its pipeline product, ZX008 for the treatment of seizures associated with Dravet syndrome.

Zogenix gains Breakthrough status, but GW Pharma still ahead in Dravet syndrome

https://pharmaphorum.com/news/zogenix-gains-breakthrough-status-but-gw-pharma-still-ahead-in-dravet-syndrome/

Trending

Zogenix

Login